Literature DB >> 2087395

The delayed adverse reactions of low osmolar contrast media.

T S Higashi1, M Katayama.   

Abstract

A computer scale survey to inspect the occurrence of delayed symptoms (adverse reactions) associated with the intravenous injection of low osmolar contrast medium (LOCM) was carried out. Of the recovered 1070 questionnaires, 290 had the delayed symptoms. Excluding 59 patients having the same symptoms in the past one year without contact with the contrast medium, the overall incidence of the delayed adverse reaction is 22.8% (231/1011). The delayed symptoms include arm pain (6.0%), headache (3.6%), itching (2.3%), rash (1.5%), general fatigue (1.4%), gastrointestinal symptoms, etc. Though the chi-square test had shown significance of the occurrence of the delayed symptoms for the group with a past history of drug allergy and nasal allergy (p less than 0.05), the delayed symptoms were mainly distributed in the middle-aged female to indicate that the sexuality is the cause of the foresaid significance. Furthermore, the incidence of the objective delayed symptoms such as rash in the group who had accepted more than two examinations is lower than the incidence in the group who accepted only one examination in the survey period. The disagreement to the fact that the repeated usage of the contrast medium is the risk factor to increase the incidence of the adverse reactions indicates the contrast medium may not be the only cause for the occurrence of the delayed symptoms, e.g. other factors such as sexual and psychological factors etc. may play a more important role than the contrast medium under this type of survey.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2087395

Source DB:  PubMed          Journal:  Nihon Igaku Hoshasen Gakkai Zasshi        ISSN: 0048-0428


  3 in total

1.  Late adverse reactions to intravascular iodine based contrast media: an update.

Authors:  Marie-France Bellin; Fulvio Stacul; Judith A W Webb; Henrik S Thomsen; Sameh K Morcos; Torsten Almén; Peter Aspelin; Olivier Clement; Gertraud Heinz-Peer; Peter Reimer; Aart van der Molen
Journal:  Eur Radiol       Date:  2011-07-16       Impact factor: 5.315

2.  Delayed adverse reaction to contrast-enhanced CT: a prospective single-center study comparison to control group without enhancement.

Authors:  Shaun Loh; Sepideh Bagheri; Richard W Katzberg; Maxwell A Fung; Chin-Shang Li
Journal:  Radiology       Date:  2010-04-20       Impact factor: 11.105

3.  Intra-arterial and intravenous applications of Iosimenol 340 injection, a new non-ionic, dimeric, iso-osmolar radiographic contrast medium: phase 2 experience.

Authors:  Karoline Meurer; Michael Laniado; Norbert Hosten; Bettina Kelsch; Barry Hogstrom
Journal:  Acta Radiol       Date:  2014-06-17       Impact factor: 1.990

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.